Document Detail


Hungry bone syndrome: still a challenge in the post-operative management of primary hyperparathyroidism: a systematic review of the literature.
MedLine Citation:
PMID:  23152439     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Hungry bone syndrome (HBS) refers to the rapid, profound, and prolonged hypocalcaemia associated with hypophosphataemia and hypomagnesaemia, and is exacerbated by suppressed parathyroid hormone (PTH) levels, which follows parathyroidectomy in patients with severe primary hyperparathyroidism (PHPT) and preoperative high bone turnover. It is a relatively uncommon, but serious adverse effect of parathyroidectomy. We conducted a literature search of all available studies reporting a 'hungry bone syndrome' in patients who had a parathyroidectomy for PHPT, to identify patients at risk and address the pitfalls in their management. The severe hypocalcaemia is believed to be due to increased influx of calcium into bone, due to the sudden removal of the effect of high circulating levels of PTH on osteoclastic resorption, leading to a decrease in the activation frequency of new remodelling sites and to a decrease in remodelling space, although there is no good documentation for this. Various risk factors have been suggested for the development of HBS, including older age, weight/volume of the resected parathyroid glands, radiological evidence of bone disease and vitamin D deficiency. The syndrome is reported in 25-90% of patients with radiological evidence of hyperparathyroid bone disease vs only 0-6% of patients without skeletal involvement. There is insufficient data-based evidence on the best means to treat, minimise or prevent this severe complication of parathyroidectomy. Treatment is aimed at replenishing the severe calcium deficit by using high doses of calcium supplemented by high doses of active metabolites of vitamin D. Adequate correction of magnesium deficiency and normalisation of bone turnover are required for resolution of the hypocalcaemia which may last for a number of months after successful surgery. Preoperative treatment with bisphosphonates has been suggested to reduce post-operative hypocalcaemia, but there are to date no prospective studies addressing this issue.
Authors:
J E Witteveen; S van Thiel; J A Romijn; N A T Hamdy
Related Documents :
24442539 - The impact of alendronate on bone mineral density of osteoporotic patients.
24253959 - Less invasive stabilization system for the management of proximal tibia fractures.
2365959 - High turnover osteoporosis in acro-osteolysis (hajdu-cheney syndrome).
24662989 - 3d-fluoroscopy navigated percutaneous screw fixation of acetabular fractures.
9790989 - Osteoclastogenesis inhibitory factor (ocif) directly inhibits bone-resorbing activity o...
24318319 - Prospective randomised controlled trial of an intramedullary nail versus a sliding hip ...
16375909 - Cohesive finite element modeling of age-related toughness loss in human cortical bone.
17993069 - The safe zone for femoral cross-pin fixation: an anatomical study.
21764189 - Unerupted lower third molars and their influence on fractures of the mandibular angle a...
Publication Detail:
Type:  Journal Article; Review     Date:  2013-02-20
Journal Detail:
Title:  European journal of endocrinology / European Federation of Endocrine Societies     Volume:  168     ISSN:  1479-683X     ISO Abbreviation:  Eur. J. Endocrinol.     Publication Date:  2013 Mar 
Date Detail:
Created Date:  2013-02-21     Completed Date:  2013-04-08     Revised Date:  2013-05-08    
Medline Journal Info:
Nlm Unique ID:  9423848     Medline TA:  Eur J Endocrinol     Country:  England    
Other Details:
Languages:  eng     Pagination:  R45-53     Citation Subset:  IM    
Affiliation:
Department of Endocrinology and Metabolic Diseases, Leiden University Medical Center, Leiden, The Netherlands. j.e.witteveen@lumc.nl
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Bone Remodeling
Bone Resorption / epidemiology,  etiology,  physiopathology,  therapy*
Humans
Hyperparathyroidism, Primary / surgery*
Hypocalcemia / epidemiology,  etiology,  physiopathology,  therapy*
Hypophosphatemia / epidemiology,  etiology,  physiopathology,  therapy*
Parathyroidectomy / adverse effects*
Postoperative Complications / epidemiology,  etiology,  therapy*
Risk Factors
Severity of Illness Index
Syndrome

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Magnetic Resonance Imaging of Central Nervous System in 15043 Children with Growth Hormone Deficienc...
Next Document:  GH therapy in adult GH deficiency: a review of treatment schedules and the evidence for low starting...